| 000 | 01374 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515000302.0 | ||
| 264 | 0 | _c20060112 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/01.str.0000176498.49686.86 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsuda, Kazushi | |
| 245 | 0 | 0 |
_aInosine, calcium channels, and neuroprotection against ischemic brain injury. _h[electronic resource] |
| 260 |
_bStroke _cSep 2005 |
||
| 300 |
_a1823; author reply 1823 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAcetylcholine _xmetabolism |
| 650 | 0 | 4 | _aAdenosine A3 Receptor Antagonists |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aBrain Ischemia _xetiology |
| 650 | 0 | 4 |
_aCalcium Channels _xmetabolism |
| 650 | 0 | 4 |
_aCentral Nervous System _xdrug effects |
| 650 | 0 | 4 |
_aDihydropyridines _xpharmacology |
| 650 | 0 | 4 |
_aDizocilpine Maleate _xpharmacology |
| 650 | 0 | 4 | _aElectrophysiology |
| 650 | 0 | 4 |
_aInosine _xadministration & dosage |
| 650 | 0 | 4 | _aIschemia |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
| 773 | 0 |
_tStroke _gvol. 36 _gno. 9 _gp. 1823; author reply 1823 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.str.0000176498.49686.86 _zAvailable from publisher's website |
| 999 |
_c15757627 _d15757627 |
||